reference/23460895

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/23460895

Outgoing Links

Predicate	Object
contentType	Letter\|Randomized Controlled Trial
endingPage	1590
issn	0390-6078 1592-8721
issueIdentifier	10
pageRange	1588-1590
publicationName	Haematologica
startingPage	1588
bibliographicCitation	Voskaridou E, Christoulas D, Konstantinidou M, Tsiftsakis E, Alexakos P, Terpos E. Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial. Haematologica. 2008 Oct;93(10):1588–90. doi: 10.3324/haematol.12849. PMID: 18698086.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24b1d31619f34fa46eb14785f13c4b65 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c926a9b2b791a4bad3dc9ad245cc4c3b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62e2bc8a7b1c324c653dff1a251f720e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6e6eff3a091b5b7988985afa4367ba3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c15186a56da8aeba3d52342e0055d200 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7494674223ac3df571a61f14120fbe3f
date	2008-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/18698086 https://doi.org/10.3324/haematol.12849
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3942 https://portal.issn.org/resource/ISSN/0390-6078 https://portal.issn.org/resource/ISSN/1592-8721
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0234600 http://id.nlm.nih.gov/mesh/M0006519 http://id.nlm.nih.gov/mesh/M0011048
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D010024Q000209 http://id.nlm.nih.gov/mesh/D010024Q000188 http://id.nlm.nih.gov/mesh/D004164Q000627 http://id.nlm.nih.gov/mesh/D007093Q000627 http://id.nlm.nih.gov/mesh/D015519Q000187 http://id.nlm.nih.gov/mesh/D013789Q000150
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D010146 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D013997 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015415Q000097 http://id.nlm.nih.gov/mesh/D000077211 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D013789Q000097 http://id.nlm.nih.gov/mesh/D010024Q000097
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8738 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68740 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9395

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129728658

Total number of triples: 50.